Search

Current filters:
Add filters:

Results 1-10 of 10 (Search time: 0.003 seconds).

Item hits:

Issue DateTitleAuthor(s)
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab유대현
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab방소영
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab최찬범
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab배상철
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab이혜순
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab성윤경
2017-06Characteristics and outcomes of rheumatoid arthritis patients who started biosimilar infliximab조수경
2019-05Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study최찬범
2018-05Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials배상철
2016-04A phase III randomized study to evaluate the efficacy and safety of CT-P13 compared with reference infliximab in patients with active rheumatoid arthritis: 54-week results from the PLANETRA study유대현

Discover

BROWSE